Bluejay Diagnostics (BJDX) Capital Expenditures (2021 - 2026)
Bluejay Diagnostics (BJDX) reported Capital Expenditures of $18989.0 for Q1 2026, up 2410.1% on a YoY basis from $756.5 in Q1 2025, and down 90.52% sequentially from $200265.0 in Q4 2025.
Bluejay Diagnostics (BJDX) Capital Expenditures (2021 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 6 years of Capital Expenditures data on file, last reported at $18989.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 2410.1% year-over-year to $18989.0; the trailing twelve-month figure through Mar 2026 stood at $193546.0 (down 28.46% YoY), and the FY2025 full-year result was $173735.0, down 43.37% from the prior year.
- Capital Expenditures slipped to $18989.0 in Q1 2026, from $200265.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $791464.0 in Q3 2022 to a low of -$310496.0 in Q3 2024.
- A 5-year average of $99542.9 and a median of -$788.0 in 2022 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 25168.17% in 2024, while the deepest fall reached 17461.99% in 2024.
- Tracing BJDX's Capital Expenditures over 5 years: stood at $238207.0 in 2022, then plunged by 100.52% to -$1244.0 in 2023, then surged by 25168.17% to $311848.0 in 2024, then plunged by 35.78% to $200265.0 in 2025, then slumped by 90.52% to $18989.0 in 2026.
- Business Quant data shows BJDX's Capital Expenditures at $18989.0 in Q1 2026, $200265.0 in Q4 2025, and -$13437.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | 18,989.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,989.00 |
| Mar 31, 2026 | 18,989.00 |
| Dec 31, 2025 | 200,265.00 |
| Dec 31, 2025 | 200,265.00 |
| Sep 30, 2025 | -13,437.00 |
| Sep 30, 2025 | -13,437.00 |
| Jun 30, 2025 | -12,271.00 |
| Jun 30, 2025 | -12,271.00 |
| Mar 31, 2025 | -822.00 |
| Mar 31, 2025 | -822.00 |
| Dec 31, 2024 | 311,848.00 |
| Dec 31, 2024 | 311,848.00 |
| Sep 30, 2024 | -310,496.00 |
| Sep 30, 2024 | -310,496.00 |
| Jun 30, 2024 | 269,998.00 |
| Jun 30, 2024 | 269,998.00 |
| Mar 31, 2024 | 35,433.00 |
| Mar 31, 2024 | 35,433.00 |
| Dec 31, 2023 | -1,244.00 |
| Dec 31, 2023 | -1,244.00 |